Advanced Oncotherapy (AVO)


Latest News

Director Deals - Advanced Oncotherapy PLC (AVO)

Dr Enrico Vanni, Non Executive Director, bought 40,000 shares in the company on the 11th January 2018 at a price of 54.5...

Director dealing

RNS Number: 6753B Advanced Oncotherapy PLC 12 January 2018 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Director Dealing Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that yesterday Dr Enrico Vanni, Non-Executive Director of the Com...

Advanced Oncotherapy LIGHT system on track

Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, said it remained on...

Notice of GM

RNS Number: 3930A Advanced Oncotherapy PLC 28 December 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Notice of General Meeting Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that a circular (the "Circular") convening the Company's...

All News

12-01-18Director Deals - Advanced Oncotherapy PLC (AVO)StockMarketWire
12-01-18Director dealingRNS
28-12-17Advanced Oncotherapy LIGHT system on trackStockMarketWire
28-12-17Notice of GMRNS
28-12-17Technological updateRNS
22-12-17Holding(s) in CompanyRNS
13-12-17Holding(s) in CompanyRNS
11-12-17Hardman Res.: Distribution deal & capital increaseRNS
11-12-17Advanced Oncotherapy - Distribution agreement and Equity InvestmentsBRR Media
07-12-17Advanced Oncotherapy inks distribution deal StockMarketWire
07-12-17Distribution agreement and Equity InvestmentsRNS
23-10-17AVO - Progress at Harley Street, timelapseBRR Media
29-09-17Advanced Oncotherapy operating losses widen StockMarketWire
29-09-17Half-year ReportRNS
05-09-17Advanced Oncotherapy - Technological updateBRR Media
04-09-17Technological updateRNS
03-08-17Advance Oncotherapy - Interview with Gabriel UrwitzBRR Media
01-08-17Director Deals - Advanced Oncotherapy PLC (AVO)StockMarketWire
01-08-17Director DealingRNS
31-07-17Technological milestones update - CCL unitsRNS
19-07-17Result of AGMRNS
19-07-17Financing facility by significant shareholdersRNS
05-07-17Video and update on progress at Harley StreetRNS
05-07-17Advanced Oncotherapy - Harley Street update with Deconstruct UKBRR Media
26-06-17Final ResultsRNS
21-06-17Conversion of Convertible Loan NotesRNS
14-06-17Advanced Oncotherapy appoints senior VP of medical physics StockMarketWire
14-06-17Appointment of Senior VP of Medical PhysicsRNS
13-06-17Additional financing agreement and new appointmentRNS
12-06-17Advanced Oncotherapy update on milestones StockMarketWire
12-06-17Technological milestones updateRNS
05-06-17Update on Bracknor financingRNS
31-05-17Holding(s) in CompanyRNS
30-05-17Harley Street construction updateRNS
26-05-17Conversion of Convertible Loan NotesRNS
26-05-17Advanced Oncotherapy draws down £1.3mStockMarketWire
26-05-17Update on Bracknor financingRNS
24-05-17Conversion of convertible loan notesRNS
23-05-17Holding(s) in CompanyRNS
18-05-17Conversion of convertible loan notesRNS

RSS feeds

  • Editorial news feed for LSE:AVO Editorial
  • Regulatory news feed for LSE:AVO Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account